Bioadhesive polymers for the peroral delivery of peptide drugs

Abstract Two different classes of bioadhesive excipients which have been approved by the FDA, the anionic charged poly (acrylic acid) derivatives and the cationic charged chitosans, have been investigated with respect to their ability to improve intestinal peptide drug absorption. It was found that both polycarbophil and the chitosan derivatives Daichitosan ® VH and chitosan-glutamate (SeaCure ® + 210) enhance the absorption of the peptide drug 9-desglycinamide, 8-arginine vasopressin (DGAVP) in the vertically perfused intestinal loop model of the rat. Recent studies demonstrated that the two poly (acrylates) polycarbophil and Carbopol ® 934P are able to inhibit the activity of the proteolytic enzyme trypsin at pH 6.7, which may lead to an increased stability of the peptide drug in the intestine. The depletion of Ca 2+ out of the incubation medium due to the Ca 2+ binding properties of the poly (acrylates) is discussed as a possible mechanism of action. Because of the observation that depletion of Ca 2+ can additionally cause an opening of tight junctions, the influence of polycarbophil on the paracellular integrity of Caco-2 monolayers was also investigated by measurements of transepithelial electrical resistance (TEER) as well as by visualization studies using confocal laser scanning microscopy. At pH 4.0, apically applied polycarbophil tended to decrease TEER values stronger than the control solution, whereas at pH 7.0 no pronounced changes of TEER could be observed. At pH 7.4, polycarbophil was only able to increase the paracellular permeability of the hydrophilic model compound fluorescein-isothiocyanate-dextran ( M w 4000) when applied to the basolateral side of the Caco2 cell monolayer. In conclusion, bioadhesive polymers are promising absorption promoting agents for peroral delivery of peptide drugs, and their mechanism of action is probably a combination of inhibiting protease activities and modulating the intestinal epithelial permeability.

[1]  F. Poelma,et al.  Evaluation of a chronically isolated internal loop in the rat for the study of drug absorption kinetics. , 1987, Journal of pharmaceutical sciences.

[2]  J. Parsons,et al.  Use of liposomes to aid intestinal absorption of entrapped insulin in normal and diabetic dogs. , 1982, Biochimica et biophysica acta.

[3]  H. Junginger.  BIOADHESIVE POLYMER SYSTEMS FOR PEPTIDE DELIVERY , 1990 .

[4]  B. E. Ryman,et al.  Intrajejunal absorption of liposomally entrapped insulin in normal man [proceedings]. , 1978, Biochemical Society transactions.

[5]  M Cereijido,et al.  Experimental modulation of occluding junctions in a cultured transporting epithelium , 1980, The Journal of cell biology.

[6]  E. Touitou.  Enhancement of intestinal peptide absorption , 1992 .

[7]  D. Taylor,et al.  GI transit of potential bioadhesive formulations in man: A scintigraphic study , 1990 .

[8]  S. H. Leung,et al.  Binding of acrylic polymers to mucin/epithelial surfaces: structure-property relationships. , 1988, Critical reviews in therapeutic drug carrier systems.

[9]  N. Peppas,et al.  Bioadhesive intraoral release systems: design, testing and analysis. , 1984, Biomaterials.

[10]  D. Breimer,et al.  Cell-polarity dependent effect of chelation on the paracellular permeability of confluent caco-2 cell monolayers , 1993 .

[11]  B. Gumbiner,et al.  Structure, biochemistry, and assembly of epithelial tight junctions. , 1987, The American journal of physiology.

[12]  Claus-Michael Lehr,et al.  In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers , 1992 .

[13]  J. Robinson,et al.  Bioadhesive polymers as platforms for oral controlled drug delivery III: oral delivery of chlorothiazide using a bioadhesive polymer. , 1985, Journal of pharmaceutical sciences.

[14]  P. Couvreur,et al.  New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier , 1988, Diabetes.

[15]  C. Lehr.  BIOADHESIVE DRUG DELIVERY SYSTEMS FOR ORAL APPLICATION , 1992 .

[16]  S. S. Davis,et al.  The effect of polycarbophil on the gastric emptying of pellets , 1987, The Journal of pharmacy and pharmacology.

[17]  M. Morishita,et al.  Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation , 1992 .

[18]  D. Neckers,et al.  Vasopressin: a model for the study of effects of additives on the oral and rectal administration of peptide drugs. , 1988, Journal of pharmaceutical sciences.

[19]  Kozo Takayama,et al.  Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats , 1992 .

[20]  M. Morishita,et al.  Enteral insulin delivery by microspheres in 3 different formulations using Eudragit L100 and S100 , 1993 .

[21]  V. Lee.  Peptide and protein drug delivery , 1991 .

[22]  Claus-Michael Lehr,et al.  An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop , 1991 .

[23]  R. Greenwood,et al.  Intraduodenal Administration of Biocarrier-Insulin Systems , 1993 .

[24]  H. Bartunik,et al.  Crystal structure of bovine beta-trypsin at 1.5 A resolution in a crystal form with low molecular packing density. Active site geometry, ion pairs and solvent structure. , 1989, Journal of molecular biology.

[25]  H. Junginger,et al.  Effects of the Mucoadhesive Polymer Polycarbophil on the Intestinal Absorption of a Peptide Drug in the Rat , 1992, The Journal of pharmacy and pharmacology.

[26]  R. Kawamori,et al.  Short-Term Treatment of Alloxan-Diabetic Rats with Intrajejunal Administration of Water-in-Oil-in-Water Insulin Emulsions , 1975, Diabetes.

[27]  D. Neckers,et al.  Biodegradable azopolymer coating for oral delivery of peptide drugs. , 1990, Biochemical Society transactions.

[28]  U. Kompella,et al.  Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. , 1991, Critical reviews in therapeutic drug carrier systems.

[29]  D. Taylor,et al.  GI transit of potential bioadhesive systems in the rat , 1990 .

[30]  J D Smart,et al.  An in‐vitro investigation of mucosa‐adhesive materials for use in controlled drug delivery , 1984, The Journal of pharmacy and pharmacology.

[31]  S. Lundin,et al.  Intestinal absorption enhancement by sodium taurodihydrofusidate of a peptide hormone analogue (dDAVP) and a macromolecule (BSA) in vitro and in vivo , 1990 .

[32]  H. Patel,et al.  The Production and Evaluation of Orally Administered Insulin Nanoparticles , 1982 .

[33]  Eppstein Da,et al.  Alternative delivery systems for peptides and proteins as drugs. , 1988 .

[34]  E. Touitou,et al.  Targeted enteral delivery of insulin to rats , 1986 .

[35]  M. Danhof,et al.  Radioimmunoassay of desglycinamide-arginine vasopressin and its application in a pharmacokinetic study in the rat , 1988, Peptides.

[36]  R. H. ENGEL,et al.  Insulin: Intestinal Absorption as Water-in-Oil-in-Water Emulsions , 1968, Nature.

[37]  H. Junginger,et al.  Niosomes for oral delivery of peptide drugs , 1992 .